Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bakken

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Biorxiv : the Preprint Server for Biology|June 3, 2024
Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spreadFelix Pahmeier, Stephanie R Monticelli, Xinyi Feng, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2022
Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19Elizabeth E Zumbrun, Chengzi I Kaku, Lukas Dillinger, et al.
Viruses|December 23, 2023
SARS-CoV-2 Aerosol and Intranasal Exposure Models in FerretsElizabeth E Zumbrun, Samantha E Zak, Eric D Lee, et al.
Nature Communications|July 24, 2023
Two point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infectionMegan M Slough, Rong Li, Andrew S Herbert, et al.
Science Translational Medicine|February 19, 2025
Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spreadFelix Pahmeier, Stephanie R Monticelli, Xinyi Feng, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Finding the Goldilocks zone: Modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccineJacob Berrigan, Stephanie R Monticelli, Pieter Spealman, et al.
Mbio|April 16, 2025
Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virusAlbert Wang, Stephanie R Monticelli, Ariel S Wirchnianski, et al.
Neurobiology of Disease|November 28, 2024
Charting the shared genetic architecture of Alzheimer's disease, cognition, and educational attainment, and associations with brain developmentPiotr Jaholkowski, Shahram Bahrami, Vera Fominykh, et al.
Science (New York, N.Y.)|September 10, 2016
A "Trojan horse" bispecific-antibody strategy for broad protection against ebolavirusesAnna Z Wec, Elisabeth K Nyakatura, Andrew S Herbert, et al.
Journal of Virology|February 15, 2013
Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirusAndrew S Herbert, Ana I Kuehne, James F Barth, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Biorxiv : the Preprint Server for Biology|June 3, 2024
Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spreadFelix Pahmeier, Stephanie R Monticelli, Xinyi Feng, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2022
Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19Elizabeth E Zumbrun, Chengzi I Kaku, Lukas Dillinger, et al.
Viruses|December 23, 2023
SARS-CoV-2 Aerosol and Intranasal Exposure Models in FerretsElizabeth E Zumbrun, Samantha E Zak, Eric D Lee, et al.
Nature Communications|July 24, 2023
Two point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infectionMegan M Slough, Rong Li, Andrew S Herbert, et al.
Science Translational Medicine|February 19, 2025
Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spreadFelix Pahmeier, Stephanie R Monticelli, Xinyi Feng, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Finding the Goldilocks zone: Modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccineJacob Berrigan, Stephanie R Monticelli, Pieter Spealman, et al.
Mbio|April 16, 2025
Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virusAlbert Wang, Stephanie R Monticelli, Ariel S Wirchnianski, et al.
Neurobiology of Disease|November 28, 2024
Charting the shared genetic architecture of Alzheimer's disease, cognition, and educational attainment, and associations with brain developmentPiotr Jaholkowski, Shahram Bahrami, Vera Fominykh, et al.
Science (New York, N.Y.)|September 10, 2016
A "Trojan horse" bispecific-antibody strategy for broad protection against ebolavirusesAnna Z Wec, Elisabeth K Nyakatura, Andrew S Herbert, et al.
Journal of Virology|February 15, 2013
Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirusAndrew S Herbert, Ana I Kuehne, James F Barth, et al.
Pageof 14